These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9467485)

  • 1. The release of free prostate specific antigen into the circulation during transurethral resection of the prostate: kinetics and interaction with serum protease inhibitors.
    Coker CB; Coptcoat MJ; Mulvin D; Cuomo A; Scott N; Sherwood R
    Br J Urol; 1998 Jan; 81(1):105-8. PubMed ID: 9467485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Free/total prostate-specific antigen ratio--hope and controversies.
    Ravery V; Boccon-Gibod L
    Eur Urol; 1997; 31(4):385-8. PubMed ID: 9187894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance and metabolism of complexed and noncomplexed prostate specific antigen forms, and human glandular kallikrein 2 in clinically localized prostate cancer before and after radical prostatectomy.
    Lilja H; Haese A; Björk T; Friedrich MG; Piironen T; Pettersson K; Huland E; Huland H
    J Urol; 1999 Dec; 162(6):2029-34; discussion 2034-5. PubMed ID: 10569562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addition of purified prostate specific antigen to serum from female subjects: studies on the relative inhibition by alpha 2-macroglobulin and alpha 1-antichymotrypsin.
    Chen Z; Komatsu K; Prestigiacomo A; Stamey TA
    J Urol; 1996 Oct; 156(4):1357-63. PubMed ID: 8808871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate specific antigen predominantly forms a complex with alpha 1-antichymotrypsin in blood. Implications for procedures to measure prostate specific antigen in serum.
    Lilja H; Cockett AT; Abrahamsson PA
    Cancer; 1992 Jul; 70(1 Suppl):230-4. PubMed ID: 1376193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo and in vitro complex formation of prostate specific antigen with alpha 1-anti-chymotrypsin.
    Huber PR; Mattarelli G; Strittmatter B; van Steenbrugge GJ; Schmid HP; Maurer A
    Prostate; 1995 Sep; 27(3):166-75. PubMed ID: 7567696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer.
    Stenman UH; Leinonen J; Alfthan H; Rannikko S; Tuhkanen K; Alfthan O
    Cancer Res; 1991 Jan; 51(1):222-6. PubMed ID: 1703033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complex formation between human prostate-specific antigen and protease inhibitors in mouse plasma.
    Hekim C; Riipi T; Zhu L; Laakkonen P; Stenman UH; Koistinen H
    Prostate; 2010 Apr; 70(5):482-90. PubMed ID: 19937596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and determination of the complex between prostate-specific antigen and alpha 1-protease inhibitor in benign and malignant prostatic diseases.
    Zhang WM; Finne P; Leinonen J; Stenman UH
    Scand J Clin Lab Invest Suppl; 2000; 233():51-8. PubMed ID: 11317942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of transurethral prostatectomy on serum prostate specific antigen.
    Vesey SG; Goble NM; Stower MJ; Hammonds JC; Smith PJ
    Br J Urol; 1988 Oct; 62(4):347-51. PubMed ID: 2461243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PSA forms complexes with α1-antichymotrypsin in prostate.
    Zhu L; Jäämaa S; Af Hällström TM; Laiho M; Sankila A; Nordling S; Stenman UH; Koistinen H
    Prostate; 2013 Jan; 73(2):219-26. PubMed ID: 22806587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors.
    Christensson A; Laurell CB; Lilja H
    Eur J Biochem; 1990 Dec; 194(3):755-63. PubMed ID: 1702714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Concentrations of free form and complex form of prostate-specific antigen in serum of alpha 2 macroglobulin deficient patients with prostatic carcinoma].
    Kanoh Y; Jimbo S; Shibuya M; Matsuyama N; Mashiko T; Tanaka T; Egawa S; Ohtani H
    Rinsho Byori; 1998 Sep; 46(9):923-9. PubMed ID: 9800478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid exponential elimination of free prostate-specific antigen contrasts the slow, capacity-limited elimination of PSA complexed to alpha 1-antichymotrypsin from serum.
    Björk T; Ljungberg B; Piironen T; Abrahamsson PA; Pettersson K; Cockett AT; Lilja H
    Urology; 1998 Jan; 51(1):57-62. PubMed ID: 9457289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complex formation between PSA isoenzymes and protease inhibitors.
    Leinonen J; Zhang WM; Stenman UH
    J Urol; 1996 Mar; 155(3):1099-103. PubMed ID: 8583572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Similar rates of exponential decrease in serum concentrations of free prostate-specific antigen (PSA), PSA complexed to alpha-1-antichymotrypsin, and human glandular kallikrein 2 (hK2) in prostate cancer patients treated with GnRH-analogues.
    Björk T; Schalken J; Wittjes W; Ljungberg B; Lilja H
    Prostate; 2001 Apr; 47(1):14-20. PubMed ID: 11304725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate-specific antigen (PSA) complexed to alpha1-antichymotrypsin improves prostate cancer detection using total PSA in Japanese patients with total PSA levels of 2.0-4.0 ng/mL.
    Kobayashi T; Kamoto T; Nishizawa K; Mitsumori K; Ogura K; Ide Y
    BJU Int; 2005 Apr; 95(6):761-5. PubMed ID: 15794778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACT-PSA and complexed PSA elimination kinetics in serum after radical retropubic prostatectomy: proof of new complex forming of PSA after release into circulation.
    Stephan C; Jung K; Brux B; Lein M; Sinha P; Schnorr D; Loening SA
    Urology; 2000 Apr; 55(4):560-3. PubMed ID: 10736503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the enzymatic activity of prostate-specific antigen and its reactions with extracellular protease inhibitors in prostate cancer.
    Lilja H
    Scand J Clin Lab Invest Suppl; 1995; 220():47-56. PubMed ID: 7544478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate-specific antigen forms a complex with and cleaves alpha 1-protease inhibitor in vitro.
    Zhang WM; Leinonen J; Kalkkinen N; Stenman UH
    Prostate; 1997 Oct; 33(2):87-96. PubMed ID: 9316649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.